VOGX (Vogenx) FCF Margin %: 0.00% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

VOGX Vogenx Inc VOGX
8 GF Score
Price $14.09
View Full Analysis

What is Vogenx FCF Margin %?

Vogenx VOGX +8.38% 8 FCF Margin % is 0.00% as of Dec. 2025. GuruFocus rates VOGX with a GF Score™ of 8/100. Among 955 Biotechnology companies, Vogenx ranks worse than 104711.94% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Vogenx's Free Cash Flow for the six months ended in Dec. 2025 was $-1.11 Mil. Vogenx's Revenue for the six months ended in Dec. 2025 was $0.00 Mil. Therefore, Vogenx's FCF Margin % for the quarter that ended in Dec. 2025 was 0.00%.

As of today, Vogenx's current FCF Yield % is -0.57%.

The historical rank and industry rank for Vogenx's FCF Margin % or its related term are showing as below:


VOGX's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -78.14
* Ranked among companies with meaningful FCF Margin % only.

Vogenx FCF Margin % Related Terms

Vogenx FCF Margin % Historical Data

* Premium members only.

The historical data trend for Vogenx's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vogenx FCF Margin % Chart

Vogenx Annual Data
Trend Dec24 Dec25
FCF Margin %
0.00 0.00

Vogenx Semi-Annual Data
Dec24 Dec25
FCF Margin % 0.00 0.00

VOGX vs : FCF Margin % Comparison

For the Biotechnology subindustry, Vogenx's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vogenx FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vogenx's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Vogenx's FCF Margin % falls into.


VOGX
8GF Score
Vogenx Inc VOGX
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vogenx FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Vogenx's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-1.112/0
= %

Vogenx's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-1.112/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Vogenx (VOGX) has a FCF Margin % of 0.00% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Vogenx and its competitors. According to the industry distribution chart, Vogenx ranks #999999 out of 955 companies in the Biotechnology industry.
Is Vogenx's FCF Margin % too high?
Vogenx's current FCF Margin % is 0.00%. Based on the distribution chart, Vogenx ranks #999999 out of 955 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Vogenx has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Vogenx's FCF Margin % compare to ?
According to the Biotechnology industry distribution chart, Vogenx ranks #999999 out of 955 companies for FCF Margin %. This places Vogenx in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Vogenx and its competitors. Vogenx's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vogenx stock overvalued right now?
Vogenx (VOGX) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Vogenx's overall GF Score™ is 8/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Vogenx (VOGX), the current FCF Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vogenx Business Description

Comparable Companies
Address 3901 Barrett Drive, P.O. Box 19469, Suite 300, Raleigh, NC, USA, 27609
Vogenx Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies for the treatment of serious diseases associated with dysfunctions in human metabolism, including post-bariatric hypoglycemia, or PBH, and gastroparesis. The company's flagship product candidate, mizagliflozin, is an orally administered, minimally absorbed, small molecule drug candidate being developed for the treatment of post-bariatric hypoglycemia (PBH), gastroparesis and GIP-induced Cushing's Syndrome. It operates as a single reportable segment engaged in the discovery and development of treatments for serious metabolic and gastrointestinal diseases.
8GF Score

Get the complete analysis for VOGX

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$14.09
Price